Literature DB >> 15195893

Understanding the mechanisms of paracentesis-induced crculatory dysfunction.

Javier Sola-Vera1, José Such.   

Abstract

Large-volume paracentesis induces early beneficial haemodynamic changes that may be shortly followed by a disorder known as paracentesis-induced circulatory dysfunction, characterized by a marked activation of the renin-angiotensin axis. Evidence is accumulating however that this disorder is secondary to an accentuation of an already established arteriolar vasodilatation. The causes of this syndrome are probably multiple and may include the dynamics of paracentesis (the rate of ascitic fluid extraction), release of nitric oxide from the vascular endothelium and mechanical modifications due to abdominal decompression. Patients developing this syndrome are prone to a faster reaccumulation of ascites, renal impairment and shorter survival. Plasma volume expansion after paracentesis reduces the incidence of this disorder. Preliminary evidence suggests that other approaches, such as the use of splanchnic vasoconstrictors or modulating the rate of ascitic fluid extraction, could be also effective, although more studies are needed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15195893     DOI: 10.1097/00042737-200403000-00008

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  11 in total

1.  Predictors of large volume paracantesis induced circulatory dysfunction in patients with massive hepatic ascites.

Authors:  G Nasr; A Hassan; S Ahmed; A Serwah
Journal:  J Cardiovasc Dis Res       Date:  2010-07

Review 2.  Paracentesis-induced circulatory dysfunction: a primer for the interventional radiologist.

Authors:  Aaron J Lindsay; James Burton; Charles E Ray
Journal:  Semin Intervent Radiol       Date:  2014-09       Impact factor: 1.513

3.  Randomized, controlled pilot study comparing large-volume paracentesis using wall suction and traditional glass vacuum bottle methods.

Authors:  Monica A Konerman; Jennifer Price; Dawn Torres; Zhiping Li
Journal:  Therap Adv Gastroenterol       Date:  2014-09       Impact factor: 4.409

Review 4.  Evaluation and management of patients with refractory ascites.

Authors:  Bahaa Eldeen Senousy; Peter V Draganov
Journal:  World J Gastroenterol       Date:  2009-01-07       Impact factor: 5.742

Review 5.  Kidneys in chronic liver diseases.

Authors:  Marek Hartleb; Krzysztof Gutkowski
Journal:  World J Gastroenterol       Date:  2012-06-28       Impact factor: 5.742

6.  Albumin May Prevent the Morbidity of Paracentesis-Induced Circulatory Dysfunction in Cirrhosis and Refractory Ascites: A Pilot Study.

Authors:  Hiang Keat Tan; Paul Damien James; Florence Wong
Journal:  Dig Dis Sci       Date:  2016-04-05       Impact factor: 3.199

7.  Clinical implications of prompt ascitic drain removal in cirrhosis with refractory ascites.

Authors:  Yu Jun Wong; Huey Ming Lum; Pei Ting Tan; Eng Kiong Teo; Jessica Tan; Rahul Kumar; Prem Harichander Thurairajah
Journal:  Singapore Med J       Date:  2021-04-19       Impact factor: 1.858

8.  Hepatorenal syndrome: Update on diagnosis and therapy.

Authors:  Juan G Acevedo; Matthew E Cramp
Journal:  World J Hepatol       Date:  2017-02-28

9.  What we know about paracentesis induced circulatory dysfunction?

Authors:  Jeong Han Kim
Journal:  Clin Mol Hepatol       Date:  2015-12-24

10.  Role of Terlipressin in Cirrhotic Patients with Ascites and without Hepatorenal Syndrome: A Systematic Review of Current Evidence.

Authors:  Zhaohui Bai; Yang An; Xiaozhong Guo; Rolf Teschke; Nahum Méndez-Sánchez; Hongyu Li; Xingshun Qi
Journal:  Can J Gastroenterol Hepatol       Date:  2020-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.